Outcome and human epidermal growth factor receptor (HER) 1–4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

BACKGROUND: We have shown previously that whereas overexpression of human epidermal growth factor receptor (HER)1, HER2 and HER3 is associated with poor prognosis in breast cancer, HER4 is associated with a good prognosis. Cell proliferation is a key component of aggressive cancers and is driven by...

Descripción completa

Detalles Bibliográficos
Autores principales: Tovey, Sian M, Witton, Caroline J, Bartlett, John MS, Stanton, Peter D, Reeves, Jonathan R, Cooke, Timothy G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400680/
https://www.ncbi.nlm.nih.gov/pubmed/15084248
http://dx.doi.org/10.1186/bcr783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400680/
https://www.ncbi.nlm.nih.gov/pubmed/15084248
http://dx.doi.org/10.1186/bcr783

Ejemplares similares